RAPT (RAPT Therapeutics, Inc.) Short-Term Debt to Capital
RAPT Therapeutics, Inc. (RAPT) is a biotechnology player in the immunology sector facing clinical trial uncertainty and a shortage of R&D funding. This daily price chart confirms these challenges, where the metric stands at 0.02. The company develops safe oral agents to combat tumors through targeted cellular action. The brand is currently restoring physician confidence following the temporary suspension of several studies.
Analytical breakdowns for RAPT Therapeutics, Inc.
- stock quotes and analyst forecast:
- business market valuation indicators:
- book capitalization information:
- company liabilities and liquidity data:
Total Debt to Capital RAPT Therapeutics, Inc.|RAPT - Long-Term Debt to Capital|Short-Term Debt to Equity Ratio RAPT Therapeutics, Inc.|RAPT - Aggregate Debt Obligations|Debts to Book Capitalization RAPT Therapeutics Inc.|RAPT - Long-Term Debt Volume|Company Short-Term Debt RAPT Therapeutics|Quick Liquidity rapt.com
- company profitability and valuation multiples indicators:
Fundamental valuation:RAPT Therapeutics
For the biotechnology sector, the RAPT Therapeutics, Inc. (RAPT) chart of short-term loans to equity serves as a liquidity indicator amid an investment deficit. This metric compares the volume of liabilities with a maturity of over one year against the amount of shareholder equity. This ratio determines the company's dependence on external financing as cash reserves are depleted. An increase in this indicator against the backdrop of halted drug trials signals a critical weakening of financial stability.
Main competitors
Short-Term Debt to Capital ARGX|BNTX (BioNTech Pharma) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital ABVX (Abivax Pharma)|Short-Term Debt to Capital admabiologics.com ADMA|PTGX - Short-Term Debt to Equity|Ratio of Short-Term Indebtedness to Capital IMVT (Immunovant Inc)|Kiniksa Pharmaceuticals Ltd (KNSA) - Short-Term Debt to Equity|Short-Term Debt to Equity Ratio Grifols Biemat|ADPT (Adaptive Biotechnologies) - Short-Term Debt to Capital|Short-Term Debt to Capital celldex.com|Short-Term Debt to Equity Ratio AUPH (Aurinia Pharmaceuticals Inc.)|BCRX (BioCryst Pharmaceuticals, Inc.) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital VERA (Vera Pharma)|Short-Term Debt to Capital Coefficient Dianthus Corp (DNTH)|PHVS - Short-Term Debt to Equity|AbCellera Biologics Inc (ABCL) - Short-Term Debt to Equity Ratio|Tourmaline Bio (TRML) - Short-Term Debt to Equity|Short-Term Debt to Equity Ratio Precigen Inc|Short-Term Debt to Equity Ratio PHAR|Short-Term Debt to Capital Nektar Corp|Short-Term Debt to Equity Upstream Bio Inc (UPB)|zenasbio.com - Short-Term Debt to Capital Ratio|Short-Term Debt to Capital IMNM (Immunome)|Gossamer Bio Inc (GOSS) - Current Liabilities to Capital|KALV - Short-Term Debt to Equity|Ratio of Short-Term Indebtedness to Capital SEPN (Septerna Pharma)|PVLA: Short-Term Debt to Capital|savarapharma.com (SVRA) - Short-Term Debt to Capital|Short-Term Debt to Equity Rigel Pharmaceuticals, Inc.|AnaptysBio Inc - Current Liabilities to Equity|Short-Term Debt to Equity Ratio ATXS (Astria Pharma)|Short-Term Loans to Capital Ratio ENGN|Aerovate Therapeutics - Short-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital ACRS|KYTX: Short-Term Debt to Equity Ratio|Tiziana Life Sciences Ltd. - Short-Term Loans to Capital Ratio|CABA: Short-Term Debt to Capital|Ventyx Biosciences, Inc - Ratio of Short-Term Indebtedness to Capital|THTX (Theratechnologies Inc.) - Short-Term Debt to Capital|Current Liabilities to Capital avalotx.com AVTX|Short-Term Debt to Equity Eledon Pharmaceuticals, Inc. (ELDN)|AGEN (Agenus, Inc.) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital CLYM (Climb Bio, Inc.)|Short-Term Debt to Capital zurabio.com ZURA|ATYR - Short-Term Debt to Equity|Current Liabilities to Equity ADAG|IMA: Short-Term Debt to Capital|Current Liabilities to Capital Shattuck Labs (STTK)|Short-Term Debt to Equity Ratio EQ|Short-Term Debt to Capital Connect Pharma|Short-Term Debt to Equity Ratio IMUX (Immunic, Inc.)|Short-Term Loans to Capital Ratio ATRA|Short-Term Debt to Capital IFRX (InflaRx)|Short-Term Debt to Capital Coefficient X4 Pharmaceuticals Inc. (XFOR)|Adicet - Short-Term Debt to Capital|Celularity Inc. (CELU) - Short-Term Debt to Equity Ratio|INmune Bio, Inc. (INMB) - Short-Term Debt to Equity|BRNS - Short-Term Debt to Capital Coefficient|Short-Term Debt to Equity Ratio KZR|SABS: Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital AKTX|Short-Term Debt to Capital Coefficient enlivex.com|Short-Term Debt to Equity Q32 Bio QTTB|GOVX: Short-Term Debt to Capital Ratio|Edesa Biotech - Short-Term Debt to Capital|iBio Inc (IBIO) - Short-Term Debt to Equity Ratio|CARM (carismatx.com) - Short-Term Debt to Equity Ratio|XTLB - Short-Term Debt to Capital Coefficient|Short-Term Debt to Equity Bolt Biotherapeutics Inc.|HCWB: Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital APVO|Short-Term Debt to Capital aimimmuno.com (AIM)|Short-Term Debt to Equity Aditxt, Inc. ADTX|GRI (GRI Bio Corporation) - Current Liabilities to Equity|XRTX: Short-Term Debt to Equity Ratio|reshapelifesciences.com - Short-Term Loans to Capital Ratio|Revelation Biosciences, Inc. (REVB) - Short-Term Debt to Equity|Current Liabilities to Equity INDP (Indaptus Therapeutics Inc)|SCNI (Scinai) - Short-Term Debt to Capital|CALI: Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital AFMD|Short-Term Debt to Capital allakos.com (ALLK)|Short-Term Debt to Equity HOOKIPA Pharma HOOK|Ratio of Short-Term Indebtedness to Capital IGMS|ITOS - Short-Term Debt to Equity|Ocean Biomedical Corp (OCEA) - Short-Term Debt to Equity Ratio|TCBP: Short-Term Debt to Capital|thirdharmonicbio.com (THRD) - Short-Term Debt to Capital